Supplemental material
Hematology
Volume 28, 2023 - Issue 1
Research Article
Safety and efficacy of PD-1 and PD-L1 inhibitors in relapsed and refractory Hodgkin's lymphoma: a systematic review and meta-analysis of 20 prospective studies
Chenxi Suna The Second Hospital of Shandong University, Jinan, Shandong, People’s Republic of China
https://orcid.org/0000-0002-8139-2979View further author information
https://orcid.org/0000-0002-8139-2979View further author information, Huixian Chenb Center for Clinical Research, The Affiliated Hospital of Qingdao University, Qingdao, People’s Republic of Chinahttps://orcid.org/0000-0003-2808-5360View further author information
https://orcid.org/0000-0003-2808-5360View further author information, & Chengyun Zhengc Department of Hematology, The Second Hospital of Shandong University, Jinan, Shandong, People’s Republic of China;d Institute of Biotherapy for Hematological Malignancies, Shandong University, Jinan, Shandong, People’s Republic of China;e Shandong University-Karolinska Institute Collaboration Laboratory for Stem Cell Research, Jinan, Shandong, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6260-297XView further author information
https://orcid.org/0000-0001-6260-297XView further author information